Miguel Dictar
Miguel Dictar publishes mostly in Epidemiology, Oncology and Infectious Diseases, on topics such as Neutropenia and Cancer Infections, Mycobacterium research and diagnosis and Pneumocystis jirovecii pneumonia detection and treatment.
- World rank
- #5,200,943 of 7,710,434 ranked researchers
- Rank in Argentina
- #16,896 of 38,473
- Works
- 20
- Citations
- 224
- Citations per work
- 11.2
What does Miguel Dictar research?
Miguel Dictar's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1470.0%
- Medicine1470.0%
- Everything else422.0%
- Life Sciences28.0%
- 1Epidemiology26% of their works
- 2Oncology24% of their works
- 3Infectious Diseases16% of their works
- 4Parasitology4% of their works
- 5Molecular Medicine4% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
- Neutropenia and Cancer Infections
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Antifungal resistance and susceptibility
- Bacterial Identification and Susceptibility Testing
- Antibiotic Resistance in Bacteria
- Parasites and Host Interactions
- Trypanosoma species research and implications
Which keywords describe Miguel Dictar's research?
The keywords of their largest research topics: Epidemiology, Chemotherapy, Antimicrobial Agents, Febrile Neutropenia, Diagnosis, Treatment, Antibiotic Resistance and Immunocompromised Patients.
- Trypanosoma cruzi
- Multidrug-Resistant Bacteria
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- ESKAPE Pathogens
- Pneumonia
- Invasive Fungal Infections
- Nontuberculous Mycobacteria
- Immunocompromised Patients
- Treatment
- Febrile Neutropenia
- Chemotherapy
- Epidemiology
- Antimicrobial Agents
- Diagnosis
- Antibiotic Resistance
- Mycobacterium avium
- Candidiasis
- Pneumocystis
- Chagas Disease
- Helminth Infections
- Microorganism Identification
- Schistosomiasis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Epidemiology124 topics
- Chemotherapy112 topics
- Antimicrobial Agents91 topic
- Febrile Neutropenia91 topic
- Diagnosis72 topics
- Treatment72 topics
- Antibiotic Resistance62 topics
- Immunocompromised Patients62 topics
- Mycobacterium avium41 topic
- Nontuberculous Mycobacteria41 topic
- Candidiasis31 topic
- Invasive Fungal Infections31 topic
- Pneumocystis31 topic
- Pneumonia31 topic
- Chagas Disease21 topic
- ESKAPE Pathogens21 topic
- Helminth Infections21 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry21 topic
- Microorganism Identification21 topic
- Multidrug-Resistant Bacteria21 topic
- Schistosomiasis21 topic
- Trypanosoma cruzi21 topic
Where does Miguel Dictar work?
Miguel Dictar's main affiliation in the publication record is Instituto Alexander Fleming, Argentina.
How many publications and citations does Miguel Dictar have?
OpenAlex counts 20 works and 224 citations for Miguel Dictar, an h-index of 5, ranking #5,200,943 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Miguel Dictar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.